This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Uses of Newer Anticonvulsants: An Update

Timothy R. Berigan, DDS, MD

Published: October 1, 2002

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Since the publication of a recent review of the psychiatric uses of newer anticonvulsants in the Companion,1 2 new anticonvulsants have come to market. The first is levetiracetam,which is U.S. Food and Drug Administration-approved as an adjunctive agent in treating partial-onset seizures in adults withepilepsy.2 Its precise mechanism of action is not known, but does not appear to be due to any interaction with known mechanisms involved in inhibitory or excitatory neurotransmission.3

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 4

Quick Links: